Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.
Twenty-one patients with primary Sjögren's syndrome (SS) and 22 age- and sex-matched healthy controls were examined for levels of C3b receptors (CR1) on erythrocytes (by an enzyme-linked immunosorbent assay), levels of circulating immune complexes (IC) (by a polyethylene glycol precipitation complement consumption method), and C3 split products, C3d and C3c (by intermediate gel rocket immunoelectrophoresis). CR1 varied within a wide range (20-124%), and a preponderance of low numbers was found among patients with primary SS (P less than 0.05). The levels of circulating IC and C3d were elevated in primary SS patients (P less than 0.01) and were mutually correlated (P less than 0.01; tau = 0.5), but levels of circulating IC and C3d did not correlate with CR1 values. C3c concentrations were the same in patients and controls. It is possible that the CR1 level serves as a predictor for the development of IC-induced manifestations, and the C3d concentration serves as an objective parameter for disease activity in primary SS.
D000328:Adult; D000368:Aged; D000936:Antigen-Antibody Complex / Q000032:analysis*; D003176:Complement C3 / Q000378:metabolism*; D015932:Complement C3c; D015933:Complement C3d; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011951:Receptors, Complement / Q000378:metabolism*; D017463:Receptors, Complement 3b; D012859:Sjogren's Syndrome / Q000097:blood / Q000276:immunology*
D000936:Antigen-Antibody Complex; D003176:Complement C3; D011951:Receptors, Complement; D017463:Receptors, Complement 3b; D015932:Complement C3c; D015933:Complement C3d